Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

Blog

Depression A person raising nasal spray to demonstrate the efficacy of Spravato for NYC patients
October 2, 2025in Depression 0 Comments 0 Likes

Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression

When Depression Doesn’t Respond—Hope Still Exists with the Spravato Treatment NYC Citizens Need If you’ve been living in New York City and struggling with Depression that just won’t lift, even

by Dr. Bryan Bruno, Medical Director
Depression A hand holding a glass of water and medication pills in palm without knowing the paradoxical effect of antidepressants
September 4, 2025in Depression 0 Comments 0 Likes

Understanding the Paradoxical Effect of Antidepressants

Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges. In recent years, however, researchers have continued to question conventional wisdom by

by Dr. Bryan Bruno, Medical Director
Depression A young doctor sharing information about symptoms of Depression in older adults from his digital tablet with an older patient
September 3, 2025in Depression 0 Comments 0 Likes

Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults

For many older adults, Depression is more than just sadness. It can be persistent, debilitating, and resistant to standard treatment. In fact, a significant number of adults over the age

by Dr. Bryan Bruno, Medical Director
Depression Hands in blue surgical gloves holding Ozempic Insulin injection pen, usually for diabetics but new research suggests we may use Ozempic for mental health
September 2, 2025in Depression 0 Comments 0 Likes

Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs

GLP-1 medications like Ozempic and Wegovy show promise in treating Depression, addiction, and cognitive issues. But what are GLP-1 drugs exactly, how do they work, what promise and results have

by Dr. Bryan Bruno, Medical Director
Depression A person sitting and holding their head in their hands while looking at the pill bottles, unsure what to do when antidepressants stop working
August 31, 2025in Depression 0 Comments 0 Likes

When Antidepressants Stop Working: An Update on “Poop Out”

Antidepressants have brought relief to millions of people struggling with major depressive disorder (MDD). They can restore energy, stabilize mood, and allow patients to reclaim parts of their lives that

by Dr. Bryan Bruno, Medical Director
Depression Shot of a young couple spending time together at the beach, demonstrating how ketamine can improve quality of life for people with Depression
July 15, 2025in Depression 0 Comments 0 Likes

Does Ketamine Improve Quality of Life for People with Depression?

When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in

by Dr. Bryan Bruno, Medical Director
Depression Depression and Cardiovascular Disease
June 12, 2025in Depression 0 Comments 0 Likes

Depression and Cardiovascular Disease

Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the

by Dr. Bryan Bruno, Medical Director
Depression Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
May 27, 2025in Depression 0 Comments 0 Likes

Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe

Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading

by Dr. Bryan Bruno, Medical Director
Depression Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
May 4, 2025in Depression 0 Comments 0 Likes

Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants

Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown

by Dr. Bryan Bruno, Medical Director
Depression Can Exercise Treat Depression?
April 18, 2025in Depression 0 Comments 0 Likes

Can Exercise Treat Depression?

Depression: A Growing Global Challenge Depression is one of the world’s leading causes of disability, affecting over 280 million people worldwide. Traditional treatments—such as antidepressants and psychotherapy—help many, but they’re

by Dr. Bryan Bruno, Medical Director
Prev

Posts navigation

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 21
Next

Recent Posts

  • Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression
  • Understanding the Paradoxical Effect of Antidepressants
  • Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults
  • Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs
  • When Antidepressants Stop Working: An Update on “Poop Out”

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}